The ACAT Study is a combined prospective observational registry and randomised Phase II interventional study for patients with active cancer and acute vein thrombosis who require anticoagulation. This is an investigator-initiated study of the THANZ (Tim Brighton and Vivien Chen from THANZ, and Liz Hovey Medical Oncologist POWH).
Sorry, you are unauthorized to view this content.
Some of our website content is restricted to Members or Subcommittees.
Please login or join us to access our 'Members only' content. Or get in touch if you are a member and believe you should have access to this content.
